🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Philip Morris' Stefano Volpetti sells $1.32 million in stock

Published 02-11-2024, 01:08 am
© Reuters.
PM
-

In a recent transaction, Stefano Volpetti, the President of Smoke-Free Products and Chief Consumer Officer at Philip Morris International Inc. (NYSE:PM), sold 10,000 shares of the company's common stock. The shares were sold at a weighted average price of $132.48, with the sale amounting to a total value of approximately $1.32 million. Following this transaction, Volpetti retains ownership of 91,780 shares, which includes 26,230 restricted share units.

The sale, executed on October 31, 2024, was conducted in multiple transactions with prices ranging from $132.44 to $132.52 per share. This activity was reported in a filing with the Securities and Exchange Commission, ensuring transparency and compliance with regulatory requirements.

In other recent news, Philip Morris International Inc. has demonstrated a strong financial performance in recent times, particularly with its smoke-free products, IQOS and ZYN, driving significant organic revenue growth. According to its third-quarter earnings call, the company reported an 11.6% organic revenue growth and an 18.0% currency-neutral increase in adjusted diluted earnings per share (EPS). Notably, IQOS volumes grew by 15% year-on-year, with significant growth observed in Japan and Europe, while ZYN shipments in the U.S. saw over 40% growth.

Barclays (LON:BARC) maintained an Overweight rating on Philip Morris, raising the price target to $155 from $145, citing industry-leading revenue and EPS growth. The firm projects that the company can maintain around 7% or more EPS growth even under adverse foreign exchange (FX) conditions. This projection is further bolstered by the performance of ZYN in the U.S., which is expected to contribute significantly to earnings.

Despite potential challenges from shipment mix and supply constraints, and a proposed settlement for Canadian litigation, Philip Morris has raised its full-year guidance. The company projects a 2%-3% volume growth, 9.5% organic net revenue growth, and 14%-15% adjusted diluted EPS growth. These recent developments highlight the company's confidence in the sustainable demand for smoke-free alternatives and its plans to capture over 50% market share in low and middle-income countries.

InvestingPro Insights

Philip Morris International Inc. (NYSE:PM) continues to demonstrate strong financial performance and market positioning, as evidenced by recent InvestingPro data. The company's market capitalization stands at an impressive $203.67 billion, reflecting its significant presence in the global tobacco industry.

One of the most notable InvestingPro Tips is that Philip Morris has raised its dividend for 16 consecutive years, a testament to its consistent financial strength and commitment to shareholder returns. This aligns well with the company's current dividend yield of 4.07%, which is particularly attractive in the current market environment.

The company's financial health is further underscored by its impressive gross profit margins, another key InvestingPro Tip. With a gross profit of $23.87 billion and a gross profit margin of 64.12% for the last twelve months as of Q3 2024, Philip Morris demonstrates its ability to maintain profitability in a challenging industry landscape.

It's worth noting that Philip Morris is trading near its 52-week high, with the stock price at 97.87% of its peak. This strong performance is reflected in the company's remarkable price total returns, including a 41.53% return over the past six months and a 56.98% return over the last year.

These insights provide context to the recent insider sale by Stefano Volpetti. While executive stock sales can sometimes raise concerns, it's important to consider them in the broader context of the company's financial performance and market position.

For investors seeking a more comprehensive analysis, InvestingPro offers 15 additional tips for Philip Morris International, providing a deeper understanding of the company's financial health and market prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.